Antibiotice S.A. (BVB: ATB)
Romania
· Delayed Price · Currency is RON 2.420
-0.050 (-2.02%)
At close: Feb 3, 2025
Antibiotice Revenue
Antibiotice had revenue of 158.03M RON in the quarter ending September 30, 2024, with 4.88% growth. This brings the company's revenue in the last twelve months to 657.89M, up 8.76% year-over-year. In the year 2023, Antibiotice had annual revenue of 615.29M with 21.84% growth.
Revenue (ttm)
657.89M
Revenue Growth
+8.76%
P/S Ratio
2.45
Revenue / Employee
486.61K
Employees
1,352
Market Cap
1.61B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 615.29M | 110.29M | 21.84% |
| Dec 31, 2022 | 505.00M | 126.17M | 33.31% |
| Dec 31, 2021 | 378.83M | 31.60M | 9.10% |
| Dec 31, 2020 | 347.22M | -47.92M | -12.13% |
| Dec 31, 2019 | 395.15M | 26.45M | 7.17% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| S.P.E.E.H. Hidroelectrica | 9.83B |
| OMV Petrom | 35.62B |
| Banca Transilvania | 9.01B |
| SNGN Romgaz | 7.82B |
| BRD - Groupe Société Générale | 3.88B |
| S.N. Nuclearelectrica | 5.93B |
| Digi Communications | 11.24B |
| Societatea Energetica Electrica | 10.73B |